Sysmex Corporation (6869)

Currency in JPY
2,081.0
+3.0(+0.14%)
Closed·
Advertisement
6869 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,062.52,107.5
52 wk Range
1,246.02,227.5
Key Statistics
Bid/Ask
2,080.00 / 2,093.00
Prev. Close
2,081
Open
2,075.5
Day's Range
2,062.5-2,107.5
52 wk Range
1,246-2,227.5
Volume
2.45M
Average Volume (3m)
3.06M
1-Year Change
31.0041%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6869 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2,150.0
Upside
+3.32%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Sysmex Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Analyst Ratings

8 Buy
6 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2,150.0
(+3.32% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Buy2,200.00+5.72%1,950.00Maintain20/10/2026
JPMorgan
Buy1,900.00-8.70%1,600.00Maintain25/09/2026
Nomura/Instinet
Hold1,800.00-13.50%1,400.00Maintain27/08/2026
Citi
Hold1,900.00-8.70%1,500.00Maintain20/08/2026
Goldman Sachs
Buy1,950.00-6.30%1,700.00Maintain10/08/2026

Sysmex Corporation Earnings Call Summary for Q2/2027

  • Sysmex Q2 FY2026 EPS of $15.30 beat estimates of $14.61; revenue of $142.15B topped forecast of $134.41B; shares fell 2.63% after-hours.
  • Americas drove growth with 16.5% local-currency gain; U.S. hematology replacement rate hit 99%, while China sales plunged 22.4% on cost controls.
  • Free cash flow improved to 34B yen; operating profit reached 33B yen despite 5.7B yen goodwill impairment in clinical chemistry segment.
  • Full-year guidance unchanged: 550B yen sales, 68.5B yen operating profit; China expected down 10% in H2 as pricing revisions continue.
  • Portfolio review ongoing, focusing on four core diagnostics areas and new growth in dementia diagnostics; medical robotics venture remains unprofitable.
Last Updated: 11/11/2026, 14:18
Read Full Transcript

Earnings

Latest Release
10/11/2026
EPS / Forecast
15.30 / 14.61
Revenue / Forecast
142.15B / 134.41B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 55.82
Dividend Yield
1.88%
Industry Median 1.54%
Annualised payout
39.00
Paid unevenly
5-Years Growth
+8.45%
Growth Streak

Sysmex (6869) Income Statement & Profits

Compare 6869 to Peers and Sector

Metrics to compare
6869
Peers
Sector
Relationship
P/E Ratio
36.4x25.2x−0.2x
PEG Ratio
−1.43−1.070.00
Price/Book
2.6x2.5x2.6x
Price / LTM Sales
2.3x2.5x2.8x
Upside (Analyst Target)
3.3%14.3%63.4%
Fair Value Upside
Unlock3.7%9.5%Unlock

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers hematology, a major test routinely included in blood tests; Flow Cytometry (FCM) analyzes cell properties by irradiating individual cells with a laser and measuring the intensity of light scattering and fluorescence; urinalysis test checks for the presence of glucose, proteins, and blood in urine; clinical chemistry; hemostasis; immunochemistry; cancer gene testing; and antimicrobial susceptibility testing. The company also provides Caresphere, an ICT solution, which integrates and analyzes real time various data managed through testing instruments and clinical testing information systems, and supports the efficient operation of clinical laboratories; and involved in the medical robotics business. It serves products and services to medical institutions, clinical laboratories, animal hospitals, and research institutes. Sysmex Corporation has strategic alliance with Hologen to turn routine blood test data into clinical intelligence. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Employees
10861
Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
174.89M28.81%363.42B
Other Institutional Investors
138.86M22.87%288.56B
Public Companies & Retail Investors
293.35M48.32%609.59B
Total
607.11M100.00%1.26T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Nakatani Foundation6.37%38,692,00080,401,976
Kobe Yamabuki Zaidan, General Foundation5.93%36,000,00074,808,000

People Also Watch

2,483.50
5016
-2.65%
4,149.0
6268
-0.12%
5,984.00
6525
-0.05%
1,744.0
2801
+1.37%
11,330.0
6504
-2.50%

FAQ

What Is the Sysmex (Tokyo: 6869) Share Price Today?

The Sysmex stock price today is 2,081.0 JPY.

What Stock Exchange Does Sysmex (6869) Trade On?

Sysmex is listed and trades on the Tokyo Stock Exchange.

What Is the Ticker (Stock Symbol) for Sysmex?

The stock symbol (also called a 'ticker') for Sysmex is "6869."

Does Sysmex Pay Dividends? What’s The Current 6869 Dividend Yield?

Yes, 6869 Pays Dividends to its Shareholders. The current Sysmex dividend yield is 1.9%%.

What Is the Current Sysmex Market Capitalisation?

As of today, Sysmex (Tokyo: 6869) market cap is 1.25T JPY.

What Is Sysmex's (6869) Earnings Per Share (TTM)?

The Sysmex EPS is currently 55.82 (Trailing Twelve Months).

When Is the Next Sysmex Earnings Date?

Sysmex's next earnings report will be released on 11/02/2027.

Is 6869 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Sysmex moving averages and other technical indicators, the daily buy/sell signal for 6869 stock is Strong Buy.

How Many Times Has Sysmex Stock Split?

Sysmex has split 4 times. (See the 6869 stock split history page for full effective split date and price information.)

How Many Employees Does Sysmex Have?

Sysmex has 10861 employees, based on their latest Companies House report.

What is the current trading status of Sysmex (Tokyo: 6869)?

As of 13/11/2026, Sysmex (6869) is trading at a share price of 2,081.0 JPY, with a previous close of 2,081.0 JPY. The stock has fluctuated within a day range of 2,062.5 JPY to 2,107.5 JPY, while its 52-week range spans from 1,246.0 JPY to 2,227.5 JPY.

What Is Sysmex (6869) Price Target According to Analysts?

The average 12-month price target for Sysmex is 2,150.0 JPY, with a high estimate of 3300 JPY and a low estimate of 1500 JPY. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +3.32% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.